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L E T T E R  T O  T H E  E D I T O R
Lingonberry polyphenols: Potential SARS- CoV- 2 inhibitors as 
nutraceutical tools?
Dear Editor,
We have read with great interest the article “Mucin signature 
as a potential tool to predict susceptibility to COVID- 19” by 
Bose et al. (2021) on mucins and their glycosylation altera-
tions in the upper respiratory tract and their role in innate 
immunity and infectious disease progression. With this keep-
ing in mind, oral mucus has a distinct set of mucins (Frenkel, 
& Ribbeck, 2015) which are involved in the defense against 
pathogens capable of degrading or modifying proteins of the 
epithelial layer and saliva.
It has been proposed by Sampson et al. (2020) that oral 
bacterial burden and oral health may affect the outcome of 
COVID- 19 complications. If oral immune responses fail, 
the oral cavity acts as a passway for pathogens further to the 
lungs.
There is substantial in vitro evidence that polyphenols 
(synthesized or from natural sources) act as antiviral agents 
against viruses, such as SARS- CoV, MERS- CoV, MERS/
SARS- CoV, and their specific cysteine proteases, Epstein– 
Barr virus, enterovirus, Herpes simplex, influenza A virus, 
Coxsackievirus B1, West Nile, Zika, and Dengue viruses. 
The active molecules identified were: (−)- catechin gallate 
and (−)- gallocatechin gallate, resveratrol and its analogs, 
synthetic curcumin, polyphenols, delphinidin, quercetin and 
fisetin, and anthocyanins.
The inhibitory mechanisms of polyphenols against vi-
ruses vary depending on their composition: they include 
dose- dependent viral load or nucleocapsid protein expres-
sion reduction, inhibition of viral binding activity and rep-
lication, inhibition of viral protease and enzyme activities, 
alteration of the viral structure or membrane vesicles, stim-
ulating host's immune system by blocking viral surface gly-
coproteins or by reducing interleukin levels generating the 
anti- inflammatory outcome. Hydroxyl groups in polyphe-
nols play eventually important roles in these activities. A key 
mechanism for COVID- 19 is the upregulation of the MAPK 
p38 pathway, which plays a crucial role in the upregulation 
of proinflammatory cytokines such as interleukin- 6 (IL- 6), 
tumor necrosis factor- α (TNF- α), and IL- 1β, and loss of 
angiotensin- converting enzyme activity causing damage in 
the lungs and heart (Grimes & Grimes, 2020). It has been, 
indeed, proposed by Annunziata et al. (2020) that polyphe-
nols may have a role against coronavirus infection, and that 
polyphenolic extracts, rather than isolated polyphenols, may 
ensure these multiple actions.
Lingonberries (Vaccinium vitis idaea L.) have a unique 
phenolic composition of which at least 28 have been iden-
tified including flavonoids (anthocyanins, flavonols [e.g., 
quercetin], flavanols [catechins]), phenolic acids, lignans, 
stilbenes (resveratrol), and phenolics polymers (e.g., proan-
thocyanidins) of which anthocyanins, flavonols, and proan-
thocyanidines are the main constituents. Resveratrol may be 
extracted from berry peels and seeds. Phenolic compounds of 
lingonberries are absorbed through the intestines and retain 
their biological activity in the ileal fluid samples. In in vivo 
studies, the main anthocyanin of lingonberries cyanidin- 3- 
O- galactoside and its methylated/ glucuronidated metabo-
lites were excreted in urine or feces. Lingonberries do not 
markedly change the permeability of high permeable drugs 
in vitro.
Lingonberry cyanidin has been shown to inhibit in 
vitro p38MAPK phosphorylation, compared to blueberry 
extract, which also inhibits the phosphorylation of JNK in 
retinal photoreceptor cells after UV exposure (Ogawa et al., 
2013). Lingonberry fruit extract has been shown in vitro to 
downregulate inflammatory mediators such as IL- 6, TNF- α, 
IL- 1β, Monocyte chemotactic protein 1, cyclooxy-
genase- 2, and inducible nitric oxide synthase reduc-
ing mouse adipocyte inflammation (Kowalska et al., 
2019).
Lingonberries have also been shown to retain their ben-
eficial in vitro and in vivo antimicrobial (e.g., Candida, 
S. mutans, periodontopathogens) and anti- inflammatory 
properties in the form of fermented lingonberry juice 
in a clinical human study (Pärnänen et al., 2019). This 
study evaluates natural- based polyphenols, especially de-
rived from lingonberries, as plausible antiviral, and anti- 
inflammatory agents and this effect could be monitored 
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with an oral rinse point- of- care test. Fermented lingonberry 
juice is a safe, natural product and may be used locally as 
a mouthwash (or may be swallowed to obtain systemic 
effects) to reduce the oral microbial load and subsequent 
low- grade inflammation caused by host inflammatory cy-
tokines, for example, IL- 6, TNF- α, and by microbial ac-
tions. It is specially designed to contain low sugar content 
for safe and effective oral use.
Could it be that there are variations in innate immune 
response to pathogens in the oral cavity caused by micro-
bial burden, altered individual oral mucin- architecture 
and subsequent infection spread into the lungs and could 
these events be prevented by polyphenols from lingon-
berry? Nutritional aspects regarding COVID- 19 and future 
pandemics have been brought to attention by Jaggers et al. 
(2020) and Zabetakis et al. (2020). Severe inflammatory re-
actions are detected in COVID- 19 patients and our hypoth-
esis is that polyphenols as a nutritional tool could inhibit 
viral actions by multiple mechanisms, alleviate inflamma-
tory reactions early on in disease development, and could 
prevent the escalation of the inflammatory processes aiding 
in recovery from COVID- 19 and should be studied keeping 
in mind forthcoming pandemics.
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